TrialPanorama/TrialPanorama-database huggingface dataset:
Study 15988694 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15988694 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 1660530 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15896919 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 8923354 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 30145664 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study 18849320 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 15640411 — Surrogate Endpoint (SUR): Serum creatinine
Study 10555883 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10555883 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 10555883 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 8532768 — Monitoring Biomarker (MOI): Tissue transglutaminase
Genes: TGM2
Study 20050717 — Predictive Biomarker (PRD): USH1G mRNA
Genes: USH1G; SANS
Study 8523192 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study 31668569 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 31668569 — Predictive Biomarker (PRD): CD5 mRNA
Genes: CD5; LEU1
Study 29929873 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22266332 — Surrogate Endpoint (SUR): Serum testosterone
Study 21658561 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 19503764 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 16995328 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 11795386 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8068939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8068939 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 3174723 — Safety Biomarker (SAF): Hyaluronic acid
Study 30314560 — Predictive Biomarker (PRD): GNS mRNA
Genes: GNS
Study 14972007 — Surrogate Endpoint (SUR): Serum calcium
Study 14972007 — Surrogate Endpoint (SUR): Serum potassium
Study 2823841 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 31319554 — Surrogate Endpoint (SUR): Serum calcium
Study 16717175 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 16717175 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 16179274 — Predictive Biomarker (PRD): VDR mRNA
Genes: VDR; NR1I1
Study 16179274 — Surrogate Endpoint (SUR): Bone mineral density
Study 12538426 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 12538426 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11090789 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 11090789 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 20233439 — Surrogate Endpoint (SUR): Blood pressure
Study 12940924 — Safety Biomarker (SAF): Thiopurine S-methyltransferase
Genes: TPMT
Study 12219878 — Surrogate Endpoint (SUR): Blood pressure
Study 11606914 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 21122661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 21122661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21122661 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 21122661 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11054617 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 3221377 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31784348 — Surrogate Endpoint (SUR): Forced vital capacity
Study 23439604 — Predictive Biomarker (PRD): PLA2G7 mRNA
Genes: PLA2G7; PAFAH
Study 21062330 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 19320576 — Surrogate Endpoint (SUR): Blood pressure
Study 2175149 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 2175149 — Surrogate Endpoint (SUR): Serum potassium
Study 27217448 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 27217448 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 16573786 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 2054270 — Surrogate Endpoint (SUR): Blood pressure
Study 30316999 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 10382786 — Safety Biomarker (SAF): Interleukin 1
Study 1418276 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25137036 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29288764 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 17927634 — Surrogate Endpoint (SUR): Bacterial count
Study 28768921 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 28768921 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28768921 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 26105582 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26105582 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22464343 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 20703198 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 20703198 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study 8575241 — Surrogate Endpoint (SUR): Blood pressure
Study 25659228 — Surrogate Endpoint (SUR): Blood pressure
Study 23585310 — Predictive Biomarker (PRD): KIF6 mRNA
Genes: KIF6; C6orf102
Study 22569014 — Surrogate Endpoint (SUR): Blood pressure
Study 9041281 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study 8261468 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 20979671 — Surrogate Endpoint (SUR): Forced vital capacity
Study 27993816 — Predictive Biomarker (PRD): Hormone receptor
Study 25761742 — Surrogate Endpoint (SUR): Serum uric acid
Study 23625191 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 23625191 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 21276883 — Surrogate Endpoint (SUR): Bone mineral density
Study 11296177 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 7816001 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study 11229421 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 29681228 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29681228 — Surrogate Endpoint (SUR): Blood pressure
Study 21395643 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 10852601 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study 10852601 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 9085014 — Surrogate Endpoint (SUR): Forced vital capacity
Study 25970741 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9323470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 9323470 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 8418020 — Surrogate Endpoint (SUR): Blood pressure
Study 22935858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22935858 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 14999522 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 11153450 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 23865124 — Surrogate Endpoint (SUR): Blood pressure
Study 21629206 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 21629206 — Predictive Biomarker (PRD): NR3C2 mRNA
Genes: NR3C2; MCR; MLR
Study 19336724 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 15593225 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 28293779 — Surrogate Endpoint (SUR): Bone mineral density
Study 26639352 — Surrogate Endpoint (SUR): Blood pressure
Study 24556825 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 18418363 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 18418363 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 15539258 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 15539258 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 24433574 — Surrogate Endpoint (SUR): Serum testosterone
Study 21955035 — Surrogate Endpoint (SUR): Blood pressure
Study 8863926 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 22539783 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 20150438 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 20150438 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 20150438 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15917540 — Surrogate Endpoint (SUR): Blood pressure
Study 10570376 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 10570376 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 1846437 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 27110900 — Surrogate Endpoint (SUR): Blood pressure
Study 17369712 — Predictive Biomarker (PRD): CGN mRNA
Genes: CGN; KIAA1319
Study 17369712 — Surrogate Endpoint (SUR): Serum creatinine
Study 3549739 — Surrogate Endpoint (SUR): Blood pressure
Study 29952004 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 29952004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21878824 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 9841947 — Surrogate Endpoint (SUR): Probing pocket depth
Study 2913766 — Surrogate Endpoint (SUR): Serum testosterone
Study 2913766 — Surrogate Endpoint (SUR): Blood pressure
Study 28680341 — Surrogate Endpoint (SUR): Blood pressure
Study 23543140 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 15039128 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15039128 — Surrogate Endpoint (SUR): Blood pressure
Study 30213617 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20834044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 16405734 — Predictive Biomarker (PRD): DHDDS mRNA
Genes: DHDDS; HDS
Study 14609565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 14609565 — Safety Biomarker (SAF): IL-6 and IL-10
Study 18438908 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 15331546 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 8427943 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12707149 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 19359651 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 14754980 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study 9379690 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 30224269 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 25263836 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 25263836 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25263836 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 25263836 — Surrogate Endpoint (SUR): Blood pressure
Study 18056186 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 18056186 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 28477269 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17426065 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7955803 — Surrogate Endpoint (SUR): Blood pressure
Study 3602266 — Surrogate Endpoint (SUR): Blood pressure
Study 23233021 — Predictive Biomarker (PRD): CARS1 mRNA
Genes: CARS1; CARS
Study 20826632 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 20826632 — Surrogate Endpoint (SUR): Blood pressure
Study 26762481 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 22340303 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 17385265 — Surrogate Endpoint (SUR): Blood pressure
Study 15718412 — Surrogate Endpoint (SUR): Blood pressure
Study 16987710 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16987710 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 16987710 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 20606083 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 20606083 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 20606083 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 1707298 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 31939363 — Surrogate Endpoint (SUR): Probing pocket depth
Study 23715630 — Predictive Biomarker (PRD): Hormone receptor
Study 20657034 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 20657034 — Surrogate Endpoint (SUR): Serum calcium
Study 19583878 — Surrogate Endpoint (SUR): Blood pressure
Study 8190431 — Surrogate Endpoint (SUR): Serum calcium
Study 28345432 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study 24865782 — Surrogate Endpoint (SUR): Blood pressure
Study 15857519 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 15857519 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25123060 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25123060 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 14593453 — Surrogate Endpoint (SUR): Bone mineral density
Study 11810130 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 2609241 — Safety Biomarker (SAF): BCHE
Genes: E1
Study 31756536 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 20848528 — Predictive Biomarker (PRD): CTLA4
Genes: CD152; CD; GSE; CTLA-4
Study 27352486 — Predictive Biomarker (PRD): SDS mRNA
Genes: SDS; SDH
Study 20502909 — Surrogate Endpoint (SUR): Blood pressure
Study 17728050 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 17728050 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 10768630 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 8829312 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 8829312 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 19960492 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 18728660 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 15968676 — Predictive Biomarker (PRD): MTR mRNA
Genes: MTR
Study 15968676 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 12891211 — Surrogate Endpoint (SUR): Blood pressure
Study 30217371 — Surrogate Endpoint (SUR): Blood pressure
Study 17584482 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17584482 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17584482 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 17584482 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 17584482 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 9871429 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 154747 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28403412 — Surrogate Endpoint (SUR): Forced vital capacity
Study 21893693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19352213 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGB mRNA
Genes: FGB
Study 19352213 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 11789278 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 11789278 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 11789278 — Pharmacodynamic Biomarker (PDY): Cyclic adenosine monophosphate
Study 11789278 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 28215665 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 23401923 — Predictive Biomarker (PRD): PIP mRNA
Genes: PIP; GCDFP15; GPIP4
Study 18513526 — Surrogate Endpoint (SUR): Blood pressure
Study 16580575 — Surrogate Endpoint (SUR): Blood pressure
Study 10669338 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 10669338 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 18690345 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 18690345 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 15720047 — Surrogate Endpoint (SUR): Blood pressure
Study 30795734 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study 2658454 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 27605629 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 27605629 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 27605629 — Safety Biomarker (SAF): Hepatitis A virus cellular receptor 1
Genes: HAVCR1; KIM1; TIM1; TIMD1
Study 27605629 — Surrogate Endpoint (SUR): Serum creatinine
Study 20148806 — Predictive Biomarker (PRD): CCR4 mRNA
Genes: CCR4; CMKBR4
Study 20148806 — Predictive Biomarker (PRD): CXCR3 mRNA
Genes: CXCR3; GPR9
Study 20148806 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20148806 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ADAM11 mRNA
Genes: ADAM11; MDC
Study 20148806 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study 18719447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16115358 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 10051075 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 31807849 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29084657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 29084657 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 1417015 — Predictive Biomarker (PRD): GPT mRNA
Genes: GPT; AAT1; GPT1
Study 30797750 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 9660375 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study 9660375 — Surrogate Endpoint (SUR): Blood pressure
Study 29401318 — Predictive Biomarker (PRD): SMAD3 mRNA
Genes: SMAD3; MADH3
Study 8436158 — Surrogate Endpoint (SUR): Serum uric acid
Study 30418475 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 19632949 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 19632949 — Predictive Biomarker (PRD): CDH3 mRNA
Genes: CDH3; CDHP
Study 8031705 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8031705 — Surrogate Endpoint (SUR): Blood pressure
Study 25894749 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 25459393 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 11234740 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 12021520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 1835324 — Surrogate Endpoint (SUR): Forced vital capacity
Study 31113987 — Surrogate Endpoint (SUR): Blood pressure
Study 25073939 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 25073939 — Predictive Biomarker (PRD): MAS1 mRNA
Genes: MAS1; MAS
Study 21084399 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 21084399 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9706623 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 30571289 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 30571289 — Safety Biomarker (SAF): BDNF
Study 28214664 — Surrogate Endpoint (SUR): Blood pressure
Study 24456991 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22537824 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 17414805 — Surrogate Endpoint (SUR): Blood pressure
Study 15858814 — Surrogate Endpoint (SUR): Blood pressure
Study 24439980 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22884040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 20972285 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12